Eli Lilly avoids sanctions in Teva migraine treatment dispute

Teva Pharmaceuticals has failed to persuade a federal judge in Massachusetts that Eli Lilly should be penalised over its discovery search related to a patent dispute concerning a migraine treatment.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Americas

Teva can pursue migraine patent dispute against Eli Lilly

17 March 2022 Eli Lilly has failed to convince a US judge to toss a patent infringement lawsuit filed by Teva Pharmaceuticals in a dispute over a migraine medication.

Big Pharma

Eli Lilly can’t avoid royalties in insulin suit

21 October 2021 Eli Lilly will have to pay undetermined royalties from the net sale of its diabetes treatment to Research Corporation Technologies, an Arizona judge has ruled.

Big Pharma

UK Supreme Court invalidates Eli Lilly patent relating to Cialis

27 March 2019 The UK Supreme Court has ruled in favour of Actavis (which has been acquired by Teva) and Mylan in a patent dispute against Eli Lilly, after an earlier court found that one of Eli Lilly’s patents was invalid for lacking an inventive step.

More on this story

Americas

Teva can pursue migraine patent dispute against Eli Lilly

17 March 2022 Eli Lilly has failed to convince a US judge to toss a patent infringement lawsuit filed by Teva Pharmaceuticals in a dispute over a migraine medication.

Big Pharma

Eli Lilly can’t avoid royalties in insulin suit

21 October 2021 Eli Lilly will have to pay undetermined royalties from the net sale of its diabetes treatment to Research Corporation Technologies, an Arizona judge has ruled.

Big Pharma

UK Supreme Court invalidates Eli Lilly patent relating to Cialis

More on this story

Americas

Teva can pursue migraine patent dispute against Eli Lilly

17 March 2022 Eli Lilly has failed to convince a US judge to toss a patent infringement lawsuit filed by Teva Pharmaceuticals in a dispute over a migraine medication.

Big Pharma

Eli Lilly can’t avoid royalties in insulin suit

21 October 2021 Eli Lilly will have to pay undetermined royalties from the net sale of its diabetes treatment to Research Corporation Technologies, an Arizona judge has ruled.

Big Pharma

UK Supreme Court invalidates Eli Lilly patent relating to Cialis